NICE recommends Sobi's Doptelet to treat thrombocytopenia
Primary ITP is a rare autoimmune condition characterised by high platelet destruction - News - PharmaTimes
Source: pharmatimes.com
Stay updated with breaking news from Mervyn Morgan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Primary ITP is a rare autoimmune condition characterised by high platelet destruction - News - PharmaTimes
Therapy treats refractory chronic immune thrombocytopenia and is available across UK - News - PharmaTimes